CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new drug delivery methods for treating traumatic brain injury in children and young adults. By using biodegradable nanoparticles that can cross the blood-brain barrier, the research aims to enhance the delivery of neuroprotective compounds directly to the brain.
Traumatic brain injury (TBI) is the number one cause of disability in children and young adults.
Despite well-known mechanisms of secondary brain damage after TBI, effective treatments have not been yet established.
Consequently, novel strategies to develop therapeutics which have translational potential are urgently required.
One of the major obstacles when trying to treat the brain is the inability of drugs to cross the blood-brain barrier (BBB).
Therefore, it is of great importance to develop…
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
